Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2851618 | American Heart Journal | 2007 | 8 Pages |
Abstract
In this placebo-controlled trial after STEMI, the combination of aspirin and dipyridamole did not affect noninfarct artery disease progression. Progression did not predict long-term clinical outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hendrik-Jan MD, John K. MB, ChB, PhD, FACC, Irene C. MD, Marc A. MD, PhD, John MB, ChB, PhD, Teena M. BSc, Bruce J. MH Sc, Freek W.A. MD, PhD, FACC, Harvey D. MB, ChB, DSc, FACC,